Triple
T6563369
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | fampridine |
E153840
|
entity |
| Predicate | hasBrandName |
P40804
|
FINISHED |
| Object | Ampyra |
E153840
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ampyra | Statement: [fampridine, hasBrandName, Ampyra]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ampyra Context triple: [fampridine, hasBrandName, Ampyra]
-
A.
Namenda
Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
-
B.
fampridine
chosen
Fampridine is a potassium channel blocker medication primarily used to improve walking in adults with multiple sclerosis.
-
C.
rivastigmine
Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
-
D.
riluzole
Riluzole is a neuroprotective medication that modestly prolongs survival and slows disease progression in people with amyotrophic lateral sclerosis (ALS).
-
E.
Spinraza
Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c6880cb35881909b763eb0125236b9 |
completed | March 27, 2026, 1:37 p.m. |
| NER | Named-entity recognition | batch_69c6ae3a40488190892d20ca0d60b937 |
completed | March 27, 2026, 4:20 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c6d55fa1bc81908f2929e835051532 |
completed | March 27, 2026, 7:07 p.m. |
Created at: March 27, 2026, 1:52 p.m.